Vorinostat
Transcript of Vorinostat
Reactions 1378 - 19 Nov 2011
SVorinostat
Deep vein thrombosis, elevated creatinine andthrombocytopenia: case report
A woman was diagnosed with patch mycosis fungoides in2000 at 48 years of age. In 2007, she started oral vorinostat400 mg daily as part of her ongoing chemotherapy. Threeweeks later, her vorinostat dose was reduced to 300 mg daily,as her serum platelet count had decreased to 40 000 × 109/L.Following the ninth month of treatment, vorinostat waswithdrawn due to disease progression, deep vein thrombosis(DVT), a serum platelet count of 30 000 × 109/L and acreatinine level of 1.7mg/dL. She was scheduled to under stemcell transplantation [outcome not stated].Sanli H, et al. The efficacy of vorinostat in combination with interferon alpha andextracorporeal photopheresis in late stage mycosis fungoides and sezary syndrome.Journal of Drugs in Dermatology 10: 403-408, No. 4, Apr 2011 -Turkey 803062894
1
Reactions 19 Nov 2011 No. 13780114-9954/10/1378-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved